Skip to main content

Table 3 Univariate and multivariate analyses of the factors affecting disease-free survival (DFS) by Cox proportional hazard model

From: Correlation between spleen density and prognostic outcomes in patients with colorectal cancer after curative resection

Factors

Univariate analysis

Multivariate analysis

P-values

HR (95%CI)

P-values

HR (95%CI)

Age

0.185

1.02 (0.99—1.04)

  

BMI

0.605

0.98 (0.91—1.06)

  

Surgical duration

0.346

1.00 (1.00—1.01)

  

Length of postoperative hospital stay

0.101

1.01 (1.00—1.03)

  

Tumor size

 <4

 

Ref

  

 ≧4

0.641

1.14 (0.67—1.94)

  

Gender

 Male

 

Ref

  

 Female

0.520

0.84 (0.49—1.44)

  

Tumor location

 Rectum

 

Ref

  

 Colon

0.611

0.88 (0.53—1.45)

  

TNM

 I

 

Ref

 

Ref

 II

0.291

1.78 (0.61—5.18)

0.678

1.26 (0.42—3.75)

 III

0.009**

4.02 (1.41—11.44)

0.027*

3.39 (1.15—10.00)

 IV

0.001**

7.57 (2.21—25.89)

0.046*

4.20 (1.03—17.16)

Histologic type

 Differentiateda

 

Ref

  

 Undifferentiatedb

0.859

0.84 (0.12—6.03)

  

Anemia

 No

 

Ref

  

 Yes

0.561

1.16 (0.70—1.92)

  

Radiotherapy and chemotherapy

 No

 

Ref

  

 Yes

0.945

0.98 (0.55—1.73)

  

Previous abdominal surgery

 No

 

Ref

  

 Yes

0.066

1.75 (0.96—3.18)

  

Epidural anesthesia

 No

 

Ref

  

 Yes

0.171

0.49 (0.18—1.36)

  

Laparoscopy-assisted operation

 No

 

Ref

 

Ref

 Yes

0.006**

0.46 (0.27—0.81)

0.037*

0.53 (0.29—0.96)

Enterostomy

 No

 

Ref

  

 Yes

0.430

1.30 (0.68—2.50)

  

Combined resection

 No

 

Ref

  

 Yes

0.529

1.29 (0.59—2.83)

  

WBC > 10 G/L

 No

 

Ref

  

 Yes

0.052

1.96 (0.99—3.86)

  

Hypoalbuminemia

 No

 

Ref

 

Ref

 Yes

0.068

1.70 (0.96—3.01)

0.121

1.62 (0.88—2.97)

CEA > 9.7 ng/mL

 No

 

Ref

 

Ref

 Yes

0.004**

2.15 (1.27—3.65)

0.103

1.66 (0.90—3.05)

CA199 > 37 U/mL

 No

 

Ref

 

Ref

 Yes

 < 0.001**

2.88 (1.66—5.01)

0.010*

2.17 (1.20—3.94)

ASA score

 ≦2

 

Ref

 

Ref

 >2

0.002**

2.29 (1.36—3.85)

0.010*

2.02 (1.19—3.45)

NSR2002 score

 <3

 

Ref

  

 ≧3

0.134

1.77 (0.84—3.72)

  

CCI score

 0

 

Ref

  

 ≧1

0.009**

1.97 (1.18—3.28)

  

Estimated blood loss > 300 ml

 No

 

Ref

  

 Yes

0.972

1.02 (0.41—2.54)

  

Clavien-Dindo classification

 0-II

 

Ref

  

 III-V

0.001**

2.29 (1.38—3.79)

  

Spleen density

 non-DROSD

 

Ref

 

Ref

 DROSD

 < 0.001**

3.51 (1.96—6.31)

0.003**

2.58 (1.39—4.79)

  1. BMI Body mass index, TNM Tumor Node Metastasis, ASA, American Society of Anesthesiology, NRS2002 Nutritional Risk Screening 2002, CCI Charlson Comorbidity Index, WBC White Blood Cell, CEA Carcino Embryonic Antigen, CA199 Cancer Antigen 199.
  2. *p < 0.05, ** p < 0.01
  3. aUndifferentiated carcinomas include poorly differentiated adenocarcinomas, signet ring cell carcinomas, and mucinous carcinomas.
  4. bDifferentiated carcinomas include well or moderately differentiated, tubular or papillary adenocarcinomas.